Focus mild hypertension therapy on lifestyle changes, report says | Data show persistent increase in waist size, central obesity in U.S. | Blood pressure meds tied to higher survival in elderly
Web Version
September 18, 2014
PCNA SmartBrief
News about cardiovascular disease prevention and management

Heart Health NewsSponsored By
Focus mild hypertension therapy on lifestyle changes, report says
Lifestyle changes should be recommended for patients with mild hypertension instead of medication, researchers wrote in the British Medical Journal. The report calls for clinicians to talk with patients about exercise, smoking cessation and reduced alcohol consumption, and it recommends that clinics improve blood pressure monitoring. (9/14)
Share: LinkedInTwitterFacebookGoogle+Email
Data show persistent increase in waist size, central obesity in U.S.
Research published in the Journal of the American Medical Association found the mean waist circumference among Americans rose from 37.6 inches in 1999-2000 to 38.8 inches in 2011-2012, while the prevalence of central obesity increased from 46.4% to 54.2% during the same period. Data also revealed men had smaller increases in mean waist size and abdominal obesity compared with women. Reuters (9/16)
Share: LinkedInTwitterFacebookGoogle+Email
Blood pressure meds tied to higher survival in elderly
A meta-analysis of 11 studies involving more than 40,000 patients ages 65 and older showed use of antihypertensive drugs was associated with a significantly lower risk of heart-related death and all-cause mortality as well as lower odds of having a stroke or cardiovascular event. In one study, however, taking blood pressure drugs was linked to a 21% higher risk of falls. The findings were presented at the European Society of Cardiology 2014 Congress. Medscape (free registration)/ (Montreal) (9/11)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Earn Your RN to BSN Online While You Work — Start With 90 Credits
Complete a BSN around your work and family responsibilities via anytime, anywhere online access. Courses are eight weeks long, start six times a year and there's no app fee. Transfer up to 90 credits to graduate and improve your career prospects even faster. Start today!
Emerging Trends
Patients on generic statins more likely to stick to meds, study finds
Medicare beneficiaries who were prescribed generic statins were more likely to stick to their medication than those who received brand-name prescriptions, and they experienced better cardiovascular outcomes. The findings were reported in the Annals of Internal Medicine. News (9/15)
Share: LinkedInTwitterFacebookGoogle+Email
Study says HRT may not raise heart risks for women with AF
Research involving about 1,600 women in the AFFIRM clinical trial found hormone replacement therapy itself was not linked to mortality, stroke, thromboembolism or bleeding risk in women with atrial fibrillation, U.K. researchers reported in the journal Stroke. Medscape (free registration)/Reuters (9/17)
Share: LinkedInTwitterFacebookGoogle+Email
Stricter labels for testosterone drugs backed by FDA panel
An FDA advisory panel called for the agency to exclude normal problems related to aging from the indications for testosterone drugs, a move that could limit insurers' coverage of the hormone therapy. The experts said evidence of cardiovascular risk was mixed, and they called for clinical trials to evaluate the safety of testosterone treatments. The New York Times (tiered subscription model) (9/18)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Nursing in the News
Weston: Why the influence of nurses is growing
Four nurses, including ANA CEO Marla Weston, were included in Modern Healthcare's 2014 100 Most Influential People in Healthcare. Nurses play an important role not just in hospitals but throughout the health care system, and they will likely gain places on future lists, Weston said. "Nurses are stepping forward to be leaders, and people are understanding nurses are not just functional doers of things, but thoughtful strategists," she said. (9/12)
Share: LinkedInTwitterFacebookGoogle+Email
PCNA Update
PCNA President Barbara Fletcher to participate in AHA Scientific Sessions
PCNA President Barbara Fletcher, RN, MN, FAHA, FPCNA, FAAN, will participate in the American Heart Association Scientific Sessions this November as moderator for the joint PCNA/AHA Prevention Committee Session: Role of Physical Activity in Prevention of CVD. Topics for the session include Hemodynamic and Metabolic Effects of Physical Activity, Psychological Effects of Physical Activity, and Motivating Patients to Exercise. The AHA Scientific Sessions is a major annual cardiovascular conference for basic, translational, clinical and population science in the United States. It attracts almost 10,000 attendees and has global presence from more than 100 countries. Program objectives are to improve patient care by providing timely and significant advances in clinical, translational and population health research spanning the whole spectrum of cardiovascular disease. The AHA Scientific Sessions will take place Nov. 15-19 at McCormick Place in Chicago. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
PCNA wants YOU to submit your abstract
PCNA is accepting abstracts for the 21st Annual Symposium in April 2015 at the Anaheim Marriott, Anaheim, Calif. Health care professional involved in original data-based research or quality improvement/innovative projects related to cardiovascular risk reduction and disease management are strongly encouraged to submit an abstract. Only original abstracts will be considered (not previously published or presented prior to submitting to PCNA). Submission of an abstract constitutes a commitment by the author to present a poster if accepted. During the Symposium a first, second or third place ribbon will be placed on winning posters and all presenters and winners will be recognized during PCNA General Sessions on Friday, April 10. Learn more about how to submit your abstract.
Share: LinkedInTwitterFacebookGoogle+Email
Lead Quote
By doubting we are led to question; by questioning we arrive at the truth."
-- Pierre Abelard,
French philosopher
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about PCNA ->Join PCNA | News | Clinical Tools | Conferences & Programs | Contact
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Tom Parks
Advertising:  Rebecca Adelson
  P: 202.618.5665

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information